Fortis Healthcare (NSE:FORTIS) Total Receivables: ₹10,462 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:FORTIS Fortis Healthcare Ltd NSE:FORTIS
85 GF Score
Price ₹976.15
GF Value ₹813.69
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Fortis Healthcare Total Receivables?

Fortis Healthcare NSE:FORTIS +0.65% 85 Total Receivables is ₹10,462 Mil as of Mar. 2026. GuruFocus rates NSE:FORTIS with a GF Score™ of 85/100 and a GF Value™ of ₹813.69 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Fortis Healthcare's Total Receivables for the quarter that ended in Mar. 2026 was ₹10,462 Mil.

Fortis Healthcare Total Receivables Related Terms

Fortis Healthcare Total Receivables Historical Data

* Premium members only.

The historical data trend for Fortis Healthcare's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortis Healthcare Total Receivables Chart

Fortis Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,163.12 5,841.43 6,385.68 7,888.91 10,461.90

Fortis Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,888.91 0.00 10,197.50 0.00 10,461.90
NSE:FORTIS
85GF Score
Fortis Healthcare Ltd NSE:FORTIS
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortis Healthcare Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹10,462 Mil mean?
Fortis Healthcare (NSE:FORTIS) has a Total Receivables of ₹10,462 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fortis Healthcare and its competitors.
Is Fortis Healthcare's Total Receivables too high?
Fortis Healthcare's current Total Receivables is ₹10,462 Mil. Overall, Fortis Healthcare has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortis Healthcare's Total Receivables compare to HCA and THC?
Fortis Healthcare's Total Receivables of ₹10,462 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Providers & Services company?
A good Total Receivables depends on the Healthcare Providers & Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fortis Healthcare and its competitors. Fortis Healthcare's current Total Receivables is ₹10,462 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fortis Healthcare (NSE:FORTIS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹813.69, compared to a current price of ₹976.15 — trading 20% above its estimated fair value. The current Total Receivables is ₹10,462 Mil. Fortis Healthcare's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Fortis Healthcare (NSE:FORTIS), the current Total Receivables is ₹10,462 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortis Healthcare (NSE:FORTIS) Overvalued in 2026?

Based on GuruFocus' analysis, Fortis Healthcare stock appears to be overvalued. The current stock price of ₹976.15 is trading 20% above its estimated GF Value™ of ₹813.69. GuruFocus considers Fortis Healthcare to be Modestly Overvalued.

Key valuation signals for NSE:FORTIS:

  • Total Receivables: ₹10,462 Mil
  • GF Value™: ₹813.69 vs. price of ₹976.15 (20% above fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the NSE:FORTIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortis Healthcare Business Description

Other Exchanges 532843:India
Address Block - F, South City 1, Sector - 41, Tower-A, Unitech Business Park, Gurgaon, HR, IND, 122001
Fortis Healthcare Ltd provides integrated healthcare delivery services in India. The company manages healthcare centers including hospitals, diagnostics, and day care specialty facilities. The company's key specialty in its hospital business is cardiac sciences. It is predominantly engaged in the business of healthcare services which is the only reportable segment. The company's key hospitals include Fortis Escorts Heart Institute in Dehli, Fortis Mulund in Mumbai, and Fortis Hospital in Bengaluru. The majority of the company's revenue is derived from India.
85GF Score

Get the complete analysis for NSE:FORTIS

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹976.15
Price
₹813.69
GF Value